CFG
ZBH icon

Chapman Financial Group’s Zimmer Biomet ZBH Stock Holding History

Chapman Financial Group’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$146K Sell
1,693
-391
-19% -$34.3K 0.1% 140
2026
Q1 		$188K Sell
2,084
-520
-20% -$47.7K 0.13% 134
2025
Q4 		$234K Hold
2,604
– – 0.16% 120
2025
Q3 		$256K Buy
2,604
+215
+9% +$21.3K 0.18% 113
2025
Q2 		$218K Buy
+2,389
New +$231K 0.18% 95
2024
Q4 		$1.17M Buy
+10,972
New +$1.18M 0.94% 34

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Chapman Financial Group's ZBH Position: Q2 2026 in Review

Chapman Financial Group reduced its Zimmer Biomet (ZBH) stake by 19% in Q2 2026, selling an estimated $34.3K and leaving 1,693 shares worth $146K. The position accounts for 0.1% of the portfolio, ranked #140.

Chapman Financial Group first reported a position in ZBH in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.17M in Q4 2024. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Chapman Financial Group held 1,693 shares of Zimmer Biomet worth $146K as of Q2 2026.
  • Chapman Financial Group sold 391 Zimmer Biomet shares in Q2 2026, an estimated $34.3K.
  • Zimmer Biomet made up 0.1% of Chapman Financial Group's portfolio in Q2 2026, its #140 holding.
  • Chapman Financial Group first reported a position in Zimmer Biomet in Q4 2024 and has held it in 6 quarters since.
  • Chapman Financial Group's Zimmer Biomet position peaked at $1.17M in Q4 2024.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Chapman Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.